Formulation and In Vitro Evaluation of Polymeric Enteric Nanoparticles as Dermal Carriers with pH-Dependent Targeting Potential

    Fitsum Feleke Sahle, Benjamin Balzus, Christian Gerecke, Burkhard Kleuser, Roland Bodmeier
    Image of study
    TLDR Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.
    In a study from 2016, researchers developed pH-sensitive dexamethasone-loaded Eudragit® L 100 nanoparticles designed for controlled drug release on the skin and in hair follicles. These nanoparticles, ranging from 100–550 nm in size, were created using nanoprecipitation and exhibited high drug loading capacity (8.3%) and entrapment efficiency (85%). The formulation was found to be minimally toxic to human fibroblasts. The release of dexamethasone from the nanoparticles was dependent on the pH and buffer capacity of the surrounding medium, with extensive swelling and slow release in low buffer capacity and higher pH, and rapid erosion or dissolution at pH levels above 6.8 with a buffer capacity of 40 mM or higher. This indicates that these nanoparticles could effectively target drug delivery to the skin and hair follicles by responding to the pH environment.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    4 / 4 results

      community 6th Month Checkpoint! There is progress (I think?)

      in Progress Pictures  29 upvotes 3 weeks ago
      The conversation discusses a user's six-month progress in treating hereditary hair loss using a regimen that includes minoxidil, finasteride, dutasteride, and other medications. Opinions vary on the effectiveness and logic of the treatment, with some users suggesting additional methods like microneedling.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  36 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

    Similar Research

    5 / 1000+ results